Searched for
RANBAXY LABORATORIES
SC clears forensic audit of Fortis-IHH deal involving erstwhile Religare promoters Singh brothersThe Supreme Court has cleared the way for a Delhi High Court-appointed forensic auditor to examine transactions involving Fortis Healthcare...- Supreme Court backs Delhi HC orders in Daiichi-Fortis dispute, clears way for forensic auditThe Supreme Court has declined to interfere with Delhi High Court orders in the long-running Daiichi Sankyo-Fortis dispute, allowing a fore...
- Yes Bank moves SC against forensic audit in Fortis share sale issueYes Bank has approached the Supreme Court challenging a recent Delhi High Court directive. The court ordered a forensic audit into the sale...
- Delhi HC orders forensic audit of Fortis, Singh brothers' Rs 4,666-crore trailThe Delhi High Court ordered a forensic audit of Fortis Healthcare transactions. This audit will examine dealings with IHH Healthcare Berha...
- Delhi HC orders forensic audit of Fortis, IHH and RHT transactions in $4.6-billion Daiichi-Singh caseThe Delhi High Court on Monday ordered the appointment of a forensic auditor to examine transactions involving Fortis Healthcare, Malaysia’...
- Sell Ranbaxy Laboratories Ltd with a stop loss of Rs 739: Sandeep Wagle'Ranbaxy Laboratories Ltd is a 'SELL' call with a target of Rs 705 and a stop loss of Rs 739.'
- Sell Ranbaxy Laboratories Ltd with a target of Rs 595: Sandeep Wagle"Ranbaxy Laboratories Ltd is a 'SELL' call with a target of Rs 595 and a stop loss of Rs 634."
- Buy Ranbaxy Laboratories with target price of Rs 475: Sandeep WagleBuy Ranbaxy Laboratories with stop loss of Rs 438 for target of Rs 475.
- Buy Ranbaxy Laboratories Ltd with a target of Rs 450: Prakash GabaBuy Ranbaxy Laboratories Ltd with a target of Rs 450 and a stop loss of Rs 410: Prakash Gaba.
- Buy Ranbaxy Laboratories Ltd with target price of Rs 415: Ashwani Gujral"Ranbaxy Laboratories Ltd is a ‘BUY’ call with a target of Rs 415 and a stop loss of Rs 390."
- Buy Ranbaxy Laboratories Ltd with a target of Rs 455: Ashwani GujralRanbaxy Laboratories Ltd is a buy call with a target of Rs 455 and a stop loss of Rs 400.
- Sell Ranbaxy Laboratories Ltd with a target of Rs 360: CK NarayanRanbaxy Laboratories Ltd is a ‘SELL’ call with a target of Rs 360 and a stop loss of Rs 378.
- Buy Ranbaxy Laboratories Ltd with a target of Rs 464: Ashwani GujralRanbaxy Laboratories Ltd is a ‘BUY’ call with a stop loss of Rs 447.
- Buy Ranbaxy Laboratories Ltd with a target of Rs 465: Mitesh ThackerRanbaxy Laboratories Ltd is a 'BUY' call with a stop loss of Rs 434.
- Buy Ranbaxy Laboratories Ltd with target price of Rs 435: Ashwani GujralBuy Ranbaxy Laboratories Ltd at a stop of Rs 412.
- Sell Ranbaxy with a target of Rs 528: Ashwani GujralRanbaxy Laboratories Ltd is a ‘SELL’ call with a target of Rs 528 and a stop loss of Rs 548
- Sell Ranbaxy Laboratories with stop loss of Rs 541: Mitesh ThackerRanbaxy Laboratories Ltd is a ‘sell’ call with a target of Rs 510 and a stop loss of Rs 541.
- Buy Ranbaxy Laboratories with a target of 546-550: Prakash GabaRanbaxy Laboratories Ltd is a ‘BUY’ call with a target of Rs 546-550 and a stop loss of Rs 530.
- Buy Ranbaxy Laboratories with a target of 572: Rajat BoseRanbaxy Laboratories Ltd is a ‘BUY’ call with a target of Rs 572 and a stop loss of Rs 549.
- Buy Ranbaxy Laboratories with a target of 520: Ashwani GujralRanbaxy Laboratories Ltd is a ‘BUY’ call with a target of Rs 520 and a stop loss of Rs 506.
Load More
